GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › SCYX growth analysis
Growth stock analysis · updated 2026-07-27

SCYNEXIS, Inc. (SCYX) growth stock analysis

Is SCYNEXIS, Inc. a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Not right now by CANSLIM
15
Growth score
7
RS rating
#4,178
Rank
1/6
Traits passed
15/99
Growth score · 4178th of 4,897 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about SCYX

As of the 2026-07-27 close, SCYX scores 15 out of 99 on our growth-stock rating, a weak growth-stock profile. That ranks it 4178th of 4,897 rated US stocks, the top 85% of the market.

Its strongest trait is S (supply & demand) at 76, and its weakest is A (annual earnings growth) at 0. SCYX clears 1 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, SCYX carries a lagging Relative Strength rating of 7, meaning it has outperformed about 7% of the market over the past year.

Underneath the score: sales down 100%, trading 62% below its 52-week high, volume running 1.4× its 50-day average.

SCYX growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
55
A
Annual earnings growth
multi-year earnings trend
0
N
New highs & catalysts
proximity to new 52-week highs
0
S
Supply & demand
volume behind the move vs. share supply
76
L
Leader or laggard
Relative Strength within its group
22
I
Institutional sponsorship
fund accumulation and 13F ownership
21

Is SCYX a growth stock?

Not right now by CANSLIM

On today’s data SCYX does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

🔒 Stronger growth stocks than SCYX

The stocks ranking above SCYX today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 SCYX price history & buy range

Where SCYX sits in its base, its 52-week path, and the trait trend over the past year.

Open the full SCYX profile →

See where SCYX ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

SCYX as a growth stock, frequently asked

Is SCYX a good growth stock?

Not right now by CANSLIM. On today’s data SCYX does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

What is SCYX's growth score?

SCYNEXIS, Inc. (SCYX) scores 15 out of 99 on our growth-stock rating as of the 2026-07-27 close, ranking 4178th of 4,897 rated US stocks.

Does SCYX have strong earnings growth?

We don't have current earnings-growth figures for SCYX.

How strong is SCYX's price performance?

SCYX has a Relative Strength rating of 7, meaning it has outperformed roughly 7% of the US market over the trailing year.

Where can I see SCYX's full analysis?

Create a free Growth Stock Analyzer account to see where SCYX ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Pharmaceutical Preparations